95% CI: 0.030.67), followed in order by dulaglutide (1.04%), liraglutide (1.39%), albiglutide (5.61%), lixisenatide (8.07%), and semaglutide (18.72%)
While retatrutide is creating excitement for its potential in weight loss, it is not FDA approved and cannot be purchased legally at this time
Most dermatologists and researchers agree that GLP-1 hair loss is primarily triggered by the rapid weight loss these drugs produce, not by the drug itself damaging your hair follicles
Nooms GLP-1 Companion provides continued coaching, community support, and psychology-based tools designed to help you keep the weight off even after medication ends
If any of these occur, step back up one dose level and stabilize for four to eight weeks before attempting the reduction again
These are also responsible for the disfigurement of the body